DS Biopharma

DS Biopharma, headquartered in Dublin, Ireland, is a clinical-stage pharmaceutical company developing novel drugs based on its proprietary bioactive lipid platform to address unmet needs. These lipid molecules have been shown to be crucial in pathways of various diseases, including dermatological conditions such as atopic dermatitis (AD). The company’s lead compound, DS107 (Daleuton), is being clinically explored as a topical cream for mild to moderate AD (Phase 3 ready).